On Thursday, Uganda confirmed an outbreak of the Ebola virus in its capital city Kampala, with the first confirmed patient dying from it a day before. As per the new developments, the officials are now preparing to deploy a trial vaccine to put an end to this outbreak.

Groups of scientists are working on the vaccine and deployment of more than 2,000 doses of a candidate vaccine against the Sudan strain of Ebola has been planned and confirmed by the Uganda Virus Research Institute. As per the World Health Organization (WHO), Uganda has access to 2,169 doses of trial vaccine. For now, however, there are no approved vaccines for the strain and officials are still investigating the source of the outbreak.

The WHO had also allocated $1 million from its contingency fund for emergencies to support quick action and contain the outbreak in the country.

Confirmed Case

On Wednesday, the Sudan strain of Ebola killed a nurse employed at Kampala's main referral hospital. It is after his death that Ebola was declared an outbreak in the country. Post-mortem samples too have confirmed the Sudan Ebola Virus Disease and at least 44 contacts of the deceased man have been listed for tracing. 30 of these are health workers.

Ebola is a highly infectious hemorrhagic fever, which is transmitted through contact with bodily fluids and tissue. Symptoms include headache, vomiting of blood, muscle pains and bleeding.

it was in the late 2022, when Uganda had last suffered an Ebola outbreak. It killed 55 of the 143 people who were infected and was declared over on January 11, 2023.

What Is Ebola Virus Disease?

As per the WHO, Ebola virus disease (EVD) is a rare but severe illness in humans and is often fatal. People can get infected with the virus if they touch an infected animal when preparing food, or touch body fluids of an infected person such as saliva, urine, faeces or semen, or things that have body fluids of an infected person like clothes or sheets.

How Does Transmission Work?

Ebola enters the body through cuts in the skin or when one is touching their eyes, nose or mouth. Early symptoms include fever, fatigue and headache.

It was first discovered in 1976 in two simultaneous outbreak, when in Nzara, South Sudan and other in Yambuku, Democratic Republic of Congo. The latter occurred near a village near the Ebola River, which is where it gets its name from.

It is highly infectious and transmissible disease, in fact, there have been cases of health-care workers who have frequently been infected while treating patients with suspected or confirmed Ebola. This occurs through close contact with patients when infection control precautions are not practiced strictly.

Cases of people conducted burial ceremonies, involving direct contact with the body of the deceased too can lead to the transmission of Ebola. Even after the long suffering and recovery, there is a possibility of sexual transmission. Pregnant women who get acute Ebola and recover may still carry the virus in their breastmilk, or in pregnancy related fluids and tissues.

Symptoms:

• feeling tired
• headache
• muscle and joint pain
• eye pain and vision problems
• weight gain
• belly pain and loss of appetite
• hair loss and skin problems
• trouble sleeping
• memory loss
• hearing loss
• depression and anxiety

Ugandan health authorities have confirmed an isolated case of Marburg virus disease (MVD) in a young child who died from the highly infectious viral hemorrhagic fever.

The case comes as Uganda is already battling an outbreak of Ebola virus disease, another viral hemorrhagic fever.

According to the Africa Centres for Disease Control and Prevention (Africa CDC), the Marburg infection was detected during surveillance for the ongoing Ebola outbreak, Reuters reported.

Health officials said no contacts of the child have developed symptoms, and there are currently no active Marburg cases in the East African nation.

While a spokesperson for Uganda's Ministry of Health said they were unaware of a Marburg outbreak, the World Health Organization (WHO) confirmed it was notified of the case on June 30.

"WHO has requested further information and is supporting the local response, including case investigation, active case finding, contact tracing and community engagement," a WHO spokesperson said.

Child Death Raises Questions

Also read: Scientific Breakthrough: US Scientists Create First Synthetic Cell That Eats and Reproduces

According to Africa CDC, the case was identified in Kyegegwa district in western Uganda in a 1½-year-old child who later died.

"Africa CDC is engaging the Government of Uganda through official public health channels on reports concerning Marburg virus disease. At this stage, we cannot confirm reports of any additional case," Africa CDC spokesperson Saran Koly said.

"Africa CDC stands ready to support verification, risk assessment and response readiness as needed."

Uganda last reported a Marburg outbreak in 2017 and has experience of managing three previous outbreaks. However, responding to a potential Marburg outbreak while simultaneously battling Ebola could complicate public health efforts.

So far, Uganda has reported a total of 20 cases of the rare Bundibugyo species of Ebola, including two deaths. Of these, 15 cases were imported from the Democratic Republic of Congo.

Marburg Infection In Child 'Unusual'

The child's age has prompted questions about how the infection occurred. Abraar Karan, a global health physician and researcher at Stanford University, said infection in a toddler is unusual.

"Quite unusual -- I would suspect transmission from someone else, but there are some less-likely scenarios in which spillover could still have happened directly to a toddler," he wrote in a post on X.

Read More: WHO Issues First Clinical Care Guidelines On Ebola And Marburg Disease

What Is Marburg Virus Disease?

Marburg virus disease belongs to the same virus family as Ebola and can cause severe hemorrhagic fever. It was first recognized in 1967. MVD has a high case fatality rate ranging from 32 per cent to 88 per cent. It is transmitted to humans after a spill-over event from a wildlife reservoir such as Rousettus aegyptiacus fruit bats or their feces or contact with infected primates

Once a person is infected, the virus spreads through direct contact with the blood, bodily fluids or contaminated materials of an infected person.

Common Signs and Symptoms

Symptoms usually begin suddenly and include:

• High fever
• Severe headache
• Muscle pain
• Diarrhea
• Vomiting
• Abdominal pain
• Extreme weakness

In severe cases, patients may develop internal and external bleeding, organ failure and shock, which can be fatal.

How Can Marburg Virus Be Prevented?

There is currently no approved vaccine or specific treatment for Marburg virus disease, although several vaccines and therapies are under development. Early supportive care can improve survival.

Health authorities recommend:

• Avoid direct contact with the blood and bodily fluids of infected people.
• Avoid handling the bodies of people who died from Marburg virus disease.
• Avoid close contact with bats and wild animals, and do not handle bushmeat.

What sounds like science fiction is now a scientific reality. Researchers at the University of Minnesota have created the world's first synthetic cell built entirely from non-living chemical components that can eat, grow and reproduce—the defining characteristics of life.

The lab-made cell, named SpudCell, completes an entire life cycle and could help scientists better understand how life works while opening new possibilities in medicine, biotechnology and manufacturing.

"We've replicated in chemistry what only used to be possible in biology: the complete set of behaviors of a cell," said Associate Professor Kate Adamala. "It proves that the most fundamental functions of life... do not need a mysterious, magical spark."

The findings have been published as a preprint and have not yet been peer-reviewed.

"We have demonstrated key milestones towards construction of synthetic life: a complete cell cycle, including growth and division, and selection, in minimal cells with known identity of all components. This can serve as a chassis for further optimization of synthetic cells undergoing Darwinian evolution, advancing the field towards robust artificial life," the researchers wrote.

What Is SpudCell?

SpudCell is a synthetic cell assembled entirely from purified, non-living chemical components rather than modified living cells.

It contains:

• 36 purified enzymes
• A 90,000-base-pair genome spread across nine DNA molecules
• A lipid membrane

What Can SpudCell Do?

Replicate a Cell's Life Cycle

SpudCell can perform the essential functions of living cells, including:

• Feeding and acquiring resources
• Growing
• Replicating its genome
• Dividing
• Passing on genetically encoded traits

Unlike natural cells, SpudCell divides without a cytoskeleton. Instead, membrane-binding proteins build up on its surface until mechanical stress causes the membrane to split.

Researchers also engineered a faster-growing version of the cell. Within five generations, it outcompeted the original, demonstrating selection and evolution-like behaviour in a fully synthetic chemical system.

SpudCell: Why Is It Significant?

Scientists previously estimated that the smallest possible genome for a living cell would be around 113 kilobase pairs (kbp). SpudCell functions with just 90 kbp, making it one of the simplest known cell-like systems.

Its modular DNA design also allows researchers to program different cellular functions independently, making future synthetic cells easier to engineer.

SpudCell: Potential Applications

Researchers stated that synthetic cells could eventually perform chemical reactions beyond the reach of conventional industrial processes.

Possible applications include:

• Designing highly precise medicines
• Developing new drug molecules using amino acids not found in nature
• Producing advanced materials through biological manufacturing

"We could see materials that are grown, rather than synthesized... SpudCell provides, for the first time, a truly engineerable platform," the authors said.

SpudCell: Next steps

The researchers noted that in next steps they aim to combine the cell's multiple DNA molecules into a single stable genome, add more molecular machinery and develop common engineering standards before synthetic cells can be widely used.

"This work is just the beginning," Adamala said. "We are showing it's possible to engineer the basic functions of the cell."

Experts Urge Caution

While calling the work remarkable, Professor John Dupré of the University of Exeter questioned whether synthetic cells would outperform genetically modified bacteria in producing drugs, food, fuel and other materials.

He also argued that synthetic cells lack an important feature of living organisms—their relationships with other life forms.

"What is missing... is the relational aspect of life, which has become clear in the growing realization that life is almost universally symbiotic," he said.

An 11-year-old boy in Canada succumbed to rabies after waking up to find a bat on his face. The incident highlighted how even seemingly harmless contact with the animal, with no bites, can lead to a fatal infection if preventive treatment is not started in time, which is crucial in rabies.

Canada Boy Dies Of Rabies

The case was published in the Canadian Medical Association Journal (CMAJ). The incident occurred during the summer of 2024 while the boy was staying at a cottage in northern Ontario.

According to the report, he woke up with a bat on his face and instinctively swatted it away. His father caught the bat in a cooking pot and released it outdoors. Since there were no visible bite or scratch marks and the bat did not appear to behave aggressively, the family did not suspect rabies and seek medical attention.

However, 19 days later, the child developed facial tingling and numbness, followed by swelling, vomiting, and loss of appetite.

He was treated for a suspected viral infection initially, but his condition rapidly worsened. He went on to develop difficulty swallowing, fever, slurred speech, confusion, and visual hallucinations before being diagnosed with rabies. Despite being admitted in pediatric intensive care, he died after 17 days of admission.

Also read: The Lancet: Young Adults With Obesity Face Higher Heart Risk; Statins Benefit Older Adults

The authors of the case report said the family agreed to share the child's story to raise awareness about rabies and the importance of seeking immediate medical evaluation after any direct contact with a bat, even if there are no visible bite marks.

Bat Exposure Is Risky Even If There Are No Bite Marks

Because of this, public health authorities recommend seeking medical advice after direct contact with a bat.

Also read: Illinois Governor Claims Trump Continues To Suffer From Dementia

Immediate treatment with rabies vaccination is highly effective in preventing the disease if administered before symptoms develop. Once rabies symptoms appear, it is almost always fatal.

Rabies Remains One Of The Deadliest Infections

Human rabies cases are rare in Canada. Since 1924, only 28 human rabies cases have been reported in the country, and the Ontario child's death marked the province's first human rabies case since 1967.

While dogs remain the primary source of human rabies' deaths globally, bats are the leading source of human rabies infections acquired in North America.

According to the World Health Organization, rabies causes an estimated 59,000 human deaths every year, with the vast majority occurring in Asia and Africa.

The authors of the CMAJ case report stressed that healthcare providers should carefully assess any history of direct bat contact and consider post-exposure prophylaxis when appropriate.

They noted that early treatment is nearly 100% effective in preventing rabies before symptoms begin, making timely medical evaluation critical after any potential exposure.